422
Views
22
CrossRef citations to date
0
Altmetric
Review

Calcium silicate-based drug delivery systems

, &
Pages 215-228 | Received 30 Apr 2016, Accepted 13 Jul 2016, Published online: 11 Aug 2016

References

  • Chen JJ, Thomas JJ, Taylor HFW, et al. Solubility and structure of calcium silicate hydrate. Cem Concr Res. 2004;34:1499–1519.
  • Wenninger JA, Canterbery RC, McEwen GN Jr. International cosmetic ingredient dictionary and handbook. 8th ed. Washington (DC): Cosmetic, Toiletry, and Fragrance Association; 2000. p. 1–3.
  • Elmore AR. Final report on the safety assessment of aluminum silicate, calcium silicate, magnesium aluminum silicate, magnesium silicate, magnesium trisilicate, sodium magnesium silicate, zirconium silicate, attapulgite, bentonite, fuller’s earth, hectorite, kaolin, lithium magnesium silicate, lithium magnesium sodium silicate, montmorillonite, pyrophyllite, and zeolite. Int J Toxi. 2003;22:37–102.
  • Hench LL, Splinter RJ, Allen WC, et al. Bonding mechanisms at the interface of ceramic prosthetic materials. J Biomed Mater Res Symp. 1971;5:117–141.
  • Liu XY, Morra M, Carpi A, et al. Bioactive calcium silicate ceramics and coatings. Biomed Pharma. 2008;62:526–529.
  • Mohammadi H, Hafezi M, Nezafati N, et al. Bioinorganics in bioactive calcium silicate ceramics for bone tissue repair: bioactivity and biological properties. J Ceram Sci Technol. 2014;5:1–12.
  • Catauro M, Nunziante SP, Papale F, et al. Preparation of 0.7SiO2·0.3CaO/PCL hybrid layers via sol-gel dip coating for the surface modification of titanium implants: characterization, bioactivity and biocompatibility evaluation. J Sol-Gel Sci Technol. 2015;76:241–250.
  • Hughes E, Yanni T, Jamshidi P, et al. Inorganic cements for biomedical application: calcium phosphate, calcium sulphate and calcium silicate. Adv Appl Ceram. 2015;114:65–76.
  • Catauro M, Papale F, Roviello G, et al. Synthesis of SiO2 and CaO rich calcium silicate systems via sol-gel process: bioactivity, biocompatibility, and drug delivery tests. J Biomed Mate Res A. 2014;102:3087–3092.
  • Liu XY, Tao SY, Ding CX. Bioactivity of plasma sprayed dicalcium silicate coatings. Biomaterials. 2002;23:963–968.
  • Zhao WY, Wang JY, Zhai WY, et al. The self-setting properties and in vitro bioactivity of tricalcium silicate. Biomaterials. 2005;26:6113–6121.
  • Wu J, Zhu YJ, Cao SW, et al. Hierachically nanostructured mesoporous spheres of calcium silicate hydrate: surfactant-free sonochemical synthesis and drug-delivery system with ultrahigh drug-loading capacity. Adv Mater. 2010;22:749–753.
  • Wu J, Zhu YJ, Chen F. Ultrathin calcium silicate hydrate nanosheets with large specific surface areas: synthesis, crystallization, layered self-assembly and applications as excellent adsorbents for drug, protein, and metal ions. Small. 2013;9:2911–2925.
  • Wu J, Zhu YJ, Chen F, et al. Amorphous calcium silicate hydrate/block copolymer hybrid nanoparticles: synthesis and application as drug carriers. Dalton Trans. 2013;42:7032–7040.
  • Zhu YJ, Sham TK. The potential of calcium silicate hydrate as a carrier of ibuprofen. Expert Opin Drug Deliv. 2014;11:1337–1342.
  • Higuchi T. Mechanism of sustained-action medication. Theoretical analysis of rate of release of solid drugs dispersed in solid matrices. J Pharm Sci. 1963;52:1145–1149.
  • Andersson J, Rosenholm J, Areva S, et al. Influences of material characteristics on ibuprofen drug loading and release profiles from ordered micro- and mesoporous silica matrices. Chem Mater. 2004;16:4160–4167.
  • Vallet-Regí M, Balas F, Arcos D. Mesoporous materials for drug delivery. Angew Chem Int Ed. 2007;46:7548–7558.
  • Chen F, Zhu YJ, Zhang KH, et al. Europium-doped amorphous calcium phosphate porous nanospheres: preparation and application as luminescent drug carriers. Nanoscale Res Lett. 2011;6:67.
  • Tang QL, Zhu YJ, Wu J, et al. Calcium phosphate drug nanocarriers with ultrahigh and adjustable drug-loading capacity: one-step synthesis, in situ drug loading and prolonged drug release. Nanomedicine. 2011;7:428–434.
  • Qi C, Zhu YJ, Zhao XY, et al. Highly stable amorphous calcium phosphate porous nanospheres: microwave-assisted rapid synthesis using ATP as phosphorus source and stabilizer, and their application in anticancer drug delivery. Chem Euro J. 2013;19:981–987.
  • Ding GJ, Zhu YJ, Qi C, et al. Yolk-shell porous microspheres of calcium phosphate prepared using calcium (L)-lactate and adenosine 5ʹ-triphosphate disodium salt: application in protein/drug delivery. Chem Euro J. 2015;21:9868–9876.
  • Ding GJ, Zhu YJ, Qi C, et al. Porous hollow microspheres of amorphous calcium phosphate: soybean lecithin templated microwave-assisted hydrothermal synthesis and application in drug delivery. J Mater Chem B. 2015;3:1823–1830.
  • Gou ZG, Chang J, Zhai WY, et al. Study on the self-setting property and the in vitro bioactivity of beta-Ca2SiO4. J Biomed Mater Res B. 2005;73B:244–251.
  • Wu CT, Chang J, Fan W. Bioactive mesoporous calcium-silicate nanoparticles with excellent mineralization ability, osteostimulation, drug-delivery and antibacterial properties for filling apex roots of teeth. J Mater Chem. 2012;22:16801–16809.
  • Gong TX, Wang ZQ, Zhang YB, et al. Preparation, characterization, release kinetics, and in vitro cytotoxicity of calcium silicate cement as a risedronate delivery system. J Biomed Mater Res A. 2014;102:2295–2304.
  • Liu WN, Chang J. In vitro evaluation of gentamicin release from a bioactive tricalcium silicate bone cement. Mater Sci Eng C. 2009;29:2486–2492.
  • Chang NJ, Chen YW, Shieh DE, et al. The effects of injectable calcium silicate-based composites with the Chinese herb on an osteogenic accelerator in vitro. Biomed Mater. 2015;10:055004.
  • Chen F, Zhu YJ. Multifunctional calcium phosphate nanostructured materials and biomedical applications. Curr Nanosci. 2014;10:465–485.
  • Fan Y, Huang SS, Jiang JH, et al. Luminescent, mesoporous, and bioactive europium-doped calcium silicate (MCS:Eu3+) as a drug carrier. J Colloid Interf Sci. 2011;357:280–285.
  • Kang XJ, Huang SS, Yang PP, et al. Preparation of luminescent and mesoporous Eu3+/Tb3+ doped calcium silicate microspheres as drug carriers via a template route. Dalton Trans. 2011;40:1873–1879.
  • Zhang JH, Zhu YF, Li J, et al. Preparation and characterization of multifunctional magnetic mesoporous calcium silicate materials. Sci Technol Adv Mater. 2013;14:055009.
  • Zhu YJ, Chen F. pH-responsive drug-delivery systems. Chem Asian J. 2015;10:284–305.
  • Lu BQ, Zhu YJ, Ao HY, et al. Synthesis and characterization of magnetic iron oxide/calcium silicate mesoporous nanocomposites as a promising vehicle for drug delivery. Appl Mater Interf. 2012;4:6969–6974.
  • Lu BQ, Zhu YJ, Cheng GF, et al. Synthesis and application in drug delivery of hollow-core-double-shell magnetic iron oxide/silica/calcium silicate nanocomposites. Mater Lett. 2013;104:53–56.
  • Islam MS, Choi HN, Choi WS, et al. Polyelectrolyte-mediated hierarchical mesoporous calcium silicates: a platform for drug delivery carrier with ultrahigh loading capacity and controlled release behavior. J Mater Chem B. 2015;3:1001–1009.
  • Jain AK, Jain SK, Yadav A, et al. Controlled release calcium silicate based floating granular delivery system of ranitidine hydrochloride. Cur Drug Deliv. 2006;3:367–372.
  • Jain SK, Agrawal GP, Jain NK. A novel calcium silicate based microspheres of repaglinide: in vivo investigations. J Control Release. 2006;113:111–116.
  • Jain SK, Awasthi AM, Jain NK, et al. Calcium silicate based microspheres of repaglinide for gastroretentive floating drug delivery: preparation and in vitro characterization. J Control Release. 2005;107:300–309.
  • Jain SK, Agrawal GP, Jain NK. Evaluation of porous carrier-based floating orlistat microspheres for gastric delivery. AAPS PharmSciTech. 2006;7:E54–E62.
  • Jain SK, Agrawal GP, Jain NK. Porous carrier based floating granular delivery system of repaglinide. Drug Dev Ind Pharm. 2007;33:381–391.
  • Xue WC, Bandyopadhyay A, Bose S. Mesoporous calcium silicate for controlled release of bovine serum albumin protein. Acta Biomater. 2009;5:1686–1696.
  • Fujiwara M, Shiokawa K, Kubota T. Direct encapsulation of proteins into calcium silicate microparticles by water/oil/water interfacial reaction method and their responsive release behaviors. Mater Sci Eng C. 2012;32:2484–2490.
  • Tanuma S, Powell CJ, Penn DR. Calculations of electron inelastic mean free paths. IX. Data for 41 elemental solids over the 50 eV to 30 keV range. Surf Interf Anal. 2011;43:689–713.
  • Henderson G, Baker DR. Synchrotron radiation: earth, environmental and materials sciences applications. Ottawa: Mineralogical Association of Canada. 2002.
  • Zhou J, Zhou X, Sun X, et al. Interaction between Pt nanoparticles and carbon nanotubes – an X-ray absorption near edge structures (XANES) study. Chem Phys Lett. 2007;437:229–232.
  • Ushiro M, Uno K, Fujikawa T, et al. X-ray absorption fine structure (XAFS) analyses of Ni species trapped in graphene sheet of carbon nanofibers. Phys Rev B. 2006;73:144103.
  • Zhou J, Wang J, Liu H, et al. Imaging nitrogen in individual carbon Nanotubes. J Phys Chem Lett. 2010;1:1709–1713.
  • Ravel B. ATHENA user’s guide. 2016. Available from: http://bruceravel.github.io/demeter/documents/Athena/index.html.
  • Rehr JJ, Kas JJ, Prange MP, et al. Ab initio theory and calculations of X-ray spectra. Com Ren Phys. 2009;10:548–559.
  • Rehr JJ, Albers RC. Theoretical approaches to x-ray absorption fine structure. Rev Mod Phys. 2000;72:621–654.
  • Rámila A, Munoz B, Pérez-Pariente J, et al. Mesoporous MCM-41 as drug host system. J Sol-Gel Sci Technol. 2003;26:1199–1202.
  • Yang P, Gai S, Lin J. Functionalized mesoporous silica materials for controlled drug delivery. Chem Soc Rev. 2012;41:3679–3698.
  • Wang S. Ordered mesoporous materials for drug delivery. Micropor Mesopor Mater. 2009;117:1–9.
  • Guo XX, Wu J, Yiu YM, et al. Drug-nanocarrier interaction-tracking the local structure of calcium silicate upon ibuprofen loading with X-ray absorption near edge structure (XANES). Phys Chem Chem Phys. 2013;15:15033–15040.
  • Guo XX, Wang Z, Wu J, et al. Tracking drug loading capacities of calcium silicate hydrate carrier: a comparative X-ray absorption near edge structures study. J Phys Chem B. 2015;119:10052–10059.
  • Balas F, Manzano M, Horcajada P, et al. Confinement and controlled release of bisphosphonates on ordered mesoporous silica-based materials. J Am Chem Soc. 2006;128:8116–8117.
  • Sivakumar M, Panduranga Rao K. Preparation, characterization and in vitro release of gentamicin from coralline hydroxyapatite–gelatin composite microspheres. Biomaterials. 2002;23:3175–3181.
  • Vallet-Regí M. Ordered mesoporous materials in the context of drug delivery systems and bone tissue engineering. Chem Euro J. 2006;12:5934–5943.
  • Guttmann P, Bittencourt C, Rehbein S, et al. Nanoscale spectroscopy with polarized X-rays by NEXAFS-TXM. Nat Photon. 2011;6:25–29.
  • Bittencourt C, Hitchock AP, Ke X, et al. X-ray absorption spectroscopy by full-field X-ray microscopy of a thin graphite flake: imaging and electronic structure via the carbon K-edge. Beilstein J Nanotech. 2012;3:345–350.
  • de Smit E, Swart I, Creemer JF, et al. Nanoscale chemical imaging of a working catalyst by scanning transmission X-ray microscopy. Nature. 2008;456:222–225.
  • Felten A, Bittencourt C, Pireaux JJ, et al. Individual multiwall carbon nanotubes spectroscopy by scanning transmission X-ray Microscopy. Nano Lett. 2007;7:2435–2440.
  • Schultz BJ, Patridge CJ, Lee V, et al. Imaging local electronic corrugations and doped regions in graphene. Nature Commun. 2011;2:372.
  • Wang Z, Wang J, Sham TK, et al. Tracking the interface of an individual ZnS/ZnO nano-heterostructure. J Phys Chem C. 2012;116:10375–10381.
  • Henzler K, Guttmann P, Lu Y, et al. Electronic structure of individual hybrid colloid particles studied by near-edge X-ray absorption fine structure (NEXAFS) spectroscopy in the X-ray microscope. Nano Lett. 2013;13:824–828.
  • Guo XX, Wang Z, Wu J, et al. Imaging of drug loading distributions in individual microspheres of calcium silicate hydrate–an X-ray spectromicroscopy study. Nanoscale. 2015;7:6767–6773.
  • Siriphannon P, Kameshima Y, Yasumori A, et al. Formation of hydroxyapatite on CaSiO3 powders in simulated body fluid. J Euro Ceram Soc. 2002;22:511–520.
  • Siriphannon P, Kameshima Y, Yasumori A, et al. Comparative study of the formation of hydroxyapatite in simulated body fluid under static and flowing systems. J Biomed Mater Res. 2002;60:175–185.
  • Gou Z, Chang J. Synthesis and in vitro bioactivity of dicalcium silicate powders. J Euro Ceram Soc. 2004;24:93–99.
  • Wan X, Chang C, Mao D, et al. Preparation and in vitro bioactivities of calcium silicate nanophase materials. Mater Sci Eng C. 2005;25:455–461.
  • Long L, Chen L, Bai S, et al. Preparation of dense β-CaSiO3 ceramic with high mechanical strength and HAp formation ability in simulated body fluid. J Euro Ceram Soc. 2006;26:1701–1706.
  • Coleman NJ, Nicholson JW, Awosanya K. A preliminary investigation of the in vitro bioactivity of white portland cement. Cem Concr Res. 2007;37:1518–1523.
  • Gandolfi MG, Taddei P, Tinti A, et al. Kinetics of apatite formation on a calcium-silicate cement for root-end filling during ageing in physiological-like phosphate solutions. Clinical Oral Invest. 2010;14:659–668.
  • Tamenori Y, Morita M, Nakamura T. Two-dimensional approach to fluorescence yield XANES measurement using a silicon drift detector. J Synchrotron Radia. 2011;18:747–752.
  • Stöhr J. NEXAFS spectroscopy. Berlin: Springer; 1992.
  • Naftel S, Sham T, Yiu Y, et al. Calcium L-edge XANES study of some calcium compounds. J Synchrotron Radia. 2001;8:255–257.
  • Guo XX, Wang Z, Wu J, et al. Tracking the transformations of mesoporous microspheres of calcium silicate hydrate at the nanoscale upon ibuprofen release: a XANES and STXM study. CrystEngComm. 2015;17:4117–4124.
  • Rezwan K, Chen Q, Blaker J, et al. Biodegradable and bioactive porous polymer/inorganic composite scaffolds for bone tissue engineering. Biomaterials. 2006;27:3413–3431.
  • Dou Y, Wu C, Chang J. Preparation, mechanical property and cytocompatibility of poly (L-lactic acid)/calcium silicate nanocomposites with controllable distribution of calcium silicate nanowires. Acta Biomater. 2012;8:4139–4150.
  • Wei J, Chen F, Shin JW, et al. Preparation and characterization of bioactive mesoporous wollastonite–polycaprolactone composite scaffold. Biomaterials. 2009;30:1080–1088.
  • Cheng W, Li H, Chang J. Fabrication and characterization of β-dicalcium silicate/poly (d, l-lactic acid) composite scaffolds. Mater Lett. 2005;59:2214–2218.
  • Barta CA, Sachs-Barrable K, Jia J, et al. Lanthanide containing compounds for therapeutic care in bone resorption disorders. Dalton Trans. 2007;43:5019–5030.
  • Chen F, Huang P, Zhu YJ, et al. The photoluminescence, drug delivery and imaging properties of multifunctional Eu3+/Gd3+ dual-doped hydroxyapatite nanorods. Biomaterials. 2011;32:9031–9039.
  • Sham TK, Rosenberg RA. Time‐resolved synchrotron radiation excited optical luminescence: light‐emission properties of silicon‐based nanostructures. Chemphyschem. 2007;8:2557–2567.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.